Our findings revealed that sEV-transferred miR-342-5p may ameliorate amyloid formation in the recipient neuron cells, implying that normal exosome release of functional miRNA(s) targeting BACE1 plays a key role in AD pathology. The gene discussed is BACE1; the disease is Alzheimer disease.